volved in ROS scavenging. 10 Thioredoxin-1 (Txn1) and its corresponding reductase, thioredoxin reductase-1 (Txnrd1), are primarily localized in the cytosol, 11, 12 whereas thioredoxin-2 (Txn2) and its reductase, thioredoxin reductase-2 (Txnrd2), are both expressed in mitochondria. 13, 14 A third form, thioredoxin reductase-3, is mainly expressed in testis, and thus, has not been included in this study. 15 Txn1 has been demonstrated to participate in cardiac ROS scavenging and in limiting postischemic apoptosis and infarct size. 16, 17 By contrast, much less is known about the cardioprotective role of Txn2 and Txnrd2. The subcellular localization in mitochondria fueled speculation that Txn2 is central in the regulation of mitochondrial ROS in cardiomyocytes, given a solid 30% contribution of mitochondria to the cardiomyocyte cell volume. A potentially crucial role of Txn2 in modulating cardiac hypertrophy on stimulation by angiotensin 2 surfaced recently, 18 consistent with the notion that the hypertrophy-driving O 2 Ϫ and H 2 O 2 force is controlled by Txn2.
Unfortunately, analysis of Txnrd1 and Txnrd2, which antagonize the myocardial ROS burst at the onset of postischemic reperfusion, 19 was hampered by embryonic lethality of ubiquitous deletion of either reductase. 20, 21 To overcome this obstacle, we were able to generate mice with cardiomyocyte-specific Txnrd1 deletion, which were born at the normal Mendelian ratio and proved to be fully viable. 21 In contrast, constitutive cardiomyocyte-restricted Txnrd2 deletion caused early postnatal death, 20 prompting the generation of tamoxifen-inducible cardiac-specific Txnrd2-deficient mice. Taking advantage of cardiomyocyte-specific Txnrd1-or Txnrd2-deficient mice, we were able to define the role of mitochondrial versus cytosolic thioredoxin reductases in the scenario of I/R injury for the first time.
Materials and Methods

Heart-Specific Disruption of Txnrd1 and Txnrd2
All animal experiments were approved by the Bavarian Animal Care and Use Committee and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996, Approved Institution #A5637-01). Heart-specific inactivation of Txnrd1 was achieved by using the MLC2a-Cre transgenic mouse line, as described. 21 Tomato mice containing a fluorescence switch before (red, tomato) and after (green, eGFP) Cre activation (online-only Data Supplement Figure IA) were kindly provided by Ralf Adams, Muenster, Germany. Mice overexpressing human thioredoxin-2 (Tg hTrx2 ) were created by Dr Jiyang Cai in collaboration with Dr. Dean P. Jones, Emory University, Atlanta, Georgia. 22 Cardiac tissue-specific disruption of Txnrd2 was achieved by crossing Txnrd2 flox/mice with a heart-specific tamoxifen-inducible Cre recombinase-expressing strain 23 and feeding adult mice for 4 weeks with chow containing tamoxifen citrate (ϭTxnrd2-/-ic), 24 followed by 4 weeks of standard diet (Altromin, Lage, Germany) before I/R. For Txnrd1-/-ic and Txnrd1ϩ/-mitochondria isolation, 4 weeks of tamoxifen citrate chow were followed by 2 weeks of standard diet.
Ischemia and Reperfusion
Ischemia of the heart was induced for 90 minutes by ligation of the left anterior descending coronary artery (LAD) as described. 25 Reperfusion was then allowed for 24 hours or 14 days and followed by invasive monitoring of left ventricular function with a Millar tip catheter. The catheter was advanced through the left carotid artery and aorta into the left ventricle (LV) under continuous monitoring of the pressure curves until the diastolic pressure indicated localization in the LV. 26 N-acetylcysteine (NAC, 15 mmoles/animal) was administered intraperitoneally 15 minutes before the onset of ischemia, and cyclosporin A (CsA, 10 mg/kg intravenously via tail vein) was administered at the onset of reperfusion.
Infarct Size, TUNEL Staining, Ultrastructural Analysis
Infarct size was determined by Evans blue exclusion under conditions of LAD reocclusion. After subsequent heart excision, 3 short axis slices were incubated with triphenyl-tetrazolium-chloride (TTC) for 10 minutes. Microscopic pictures were taken and analyzed using planimetry (ImageJ; NIH, Bethesda, MD). TUNEL-positive cells were obtained from the ischemic region using ApopTag Kit (Millipore, Schwalbach, Germany) according to the manufacturer's guidelines. Nuclei were counterstained with DAPI (Vector Laboratories, Burlingame, CA).
For ultrastructural analysis, hearts were isolated and immediately fixed in 2.5% glutaraldehyde-2% paraformaldehyde (PFA). Samples were embedded in propylenoxyd and Polyembed 812 (Plano, Wetzlar, Germany). Ultrathin sections (60 nm) were stained with uranyl acetate and lead acetate and then examined on a Zeiss (Oberkochen, Germany) 902 electron microscope at 80 kV.
Embryonic Endothelial Progenitor Cells (eEPC) and Embryonic Stem (ES) Cell-Derived Cardiomyoytes
Vascular progenitor cells were derived from ubiquitous Txnrd2-/murine embryos (E7.75) according to a protocol established by Hatzopoulos et al. 27 ES cell lines were established from E3.5 embryos from matings with Txnrd2 ϩ/flox and Txnrd2 flox/flox mice. 20 ES cell clones were stably transfected with the plasmid pCAG-3SIP-MerCreMer by electroporation and selected by 1 g/mL puromycin as described. 28 Subsequently, MerCreMer-expressing ES cell clones were transfected with the plasmid pMHC-neo-PGK-Hyg (a kind gift from Loren Field, Indianapolis, IN). 29 Cardiomyocyte selection was performed by hygromycin addition at d14 after leukocyte inhibiting factor (LIF) withdrawal (initiating differentiation). Activation of Cre-recombinase and excision of the floxed Txnrd2 allele was performed by 4-hydroxytamoxifen addition for 72 hours (1 mol/L). Hypoxia (Ͻ1% oxygen) was induced by superfusing cell cultures with nitrogen for 18 hours before 4 hours' reoxygenation in the case of cardiomyocytes, and for 6 hours before 2 hours' reoxygenation with eEPCs. For fluorescence microscopy, DAPI (Vector Laboratories, Burlingame, CA) was used; for nuclear staining, troponin-I and ␣-MHC antibodies (both Santa Cruz) were used.
Adult HL-1 Cell Knockdown of Thioredoxin Reductase-2
To generate small hairpin RNA against murine Txnrd2, we used 5ЈATCCGGGAAATCCTCAACCTTAATGCTTCCTGTCAGACAT TAAGGTTGAGGATTTCCCTTTTTG -3Ј (targeting 1187-1207bp in the Txnrd2 mRNA) and the scrambled sequence oligonucleotide 5ЈGA TCCGGAAATGTCTCGTTCAGAGCTCTTCCTGTCAGA-AGCTCT GAACGAGACATTTCCTTTTTG3Ј. Oligonucleotides were ligated into the pGreenPuro vector (System Biosciences). HL-1 cells were plated on fibronectin-coated plates and cultured with Claycomb media (Sigma) for transduction with lentivirus using a MOI of 1000/cell in the presence of 8 g/mL Polybren (Sigma). Puromycin (50 g/mL) was added 48 hours after infection for another 48 hours. Hypoxia was induced for 12 hours (Ͻ1% O 2 ) followed by reoxygenation (1 hour).
Protein Isolation, Protein Concentration Determination, and Immunoblotting
Protein isolation, protein concentration determination, and immunoblotting are described in detail in the online-only Data Supplement Methods.
Determination of Reduced Glutathione
Intracellular GSH levels were measured in Txnrd2 -/cells by highperformance liquid chromatography in normoxic cells and after hypoxia/reoxygenation, as described. 30
Mitochondria: Isolation and Functional Analysis
Detailed methods are described in the online-only Data Supplement Methods. In brief, mitochondria were freshly isolated from Txnrd2-/-ic and control hearts by differential centrifugation according to standard protocols. 31 Functional integrity of isolated mitochondria was routinely assessed with a Clark type oxygen electrode (Oxygraph™, Hansatech Instruments Ltd, UK). Permeability-transition-induced swelling of mitochondrial suspensions was measured by light scattering at 540 nm, as described recently. 31 The generation of ROS was monitored by measuring the fluorescence of dichlorofluorescein with a SynergyHT2™ Multi-Mode Microplate Reader (Bio-Tek, Bad Friedrichshall, Germany) (Ex 485/20; Em 528/20). 32 Superoxide production was measured enzymatically after conversion to H 2 O 2 and expressed as H 2 O 2 release from intact mitochondria as described. 33 After I/R, aconitase activities (nϭ10
where n is the number of measurements; Cayman Chemicals, Ann Arbor, MI) were normalized to their normoxic counterparts (set to 100%), averaged, and subjected to statistical analyses.
Statistical Analysis
The results are given as meanϮSEM. Statistical analysis of results among Ͼ2 experimental groups was performed with one-way analysis of variance (ANOVA). Whenever a significant effect was obtained with ANOVA, we performed multiple comparison tests among the groups using the Student Newman Keul's procedure. For comparing just two experimental groups, Student's t test was applied. All procedures were performed with an SPSS statistical program (Version 19) after Shapiro Wilk and Levene testing for normality and equality of variances. Differences between groups were considered significant at PϽ0.05.
Results
Role of Thioredoxin Reductase-1 Deficiency During Ischemia/Reperfusion
We first investigated the impact of Txnrd1-knockout on cardiac injury inflicted by ischemia (90 minutes) and reperfusion (24 hours). Immunoblotting of heart-specific Txnrd1 knockout mice (Txnrd1-/-) ( Figure 1A ) revealed a steep decrease of Txnrd1 in heart tissue ( Figure 1B ). Low Txnrd1 quantities were still detectable due to either mosaic expression of Cre in the cardiomyocytes or, most likely, the presence of noncardiomyocyte cells like vascular cells and fibroblasts, which also express Txnrd1. On I/R, Txnrd1-/hearts differed from sham-operated experimental groups but did not notably differ from Txnrd1ϩ/-hearts in their ability to maintain a residual LV function (LVDP after I/R: Txnrd1-/-82Ϯ4 versus Txnrd1ϩ/-81Ϯ2 mm Hg at rest and 123Ϯ6 versus 114Ϯ4 mm Hg at 50 ng norepinephrine stimulation; no significant difference for each condition) ( Figure 1C These findings indicate that endogenous Txnrd1 does not fulfill an essential function in cardioprotection against oxidative stress as provided by postischemic reperfusion following 90 minutes' LAD occlusion.
Role of Thioredoxin-2 Overexpression During Ischemia/Reperfusion
Next, we assessed postischemic cardioprotection in murine hearts overexpressing human Txn2 (TG hTxn2 ). 18 Under basal conditions, no significant difference was obtained for LVDP in TG hTxn2 mice subjected to I/R compared with littermate controls, although under stimulation with 25 and 50 ng of norepinephrine (NE), cardiac performance increased in TG hTxn2 mice (LVDP 134Ϯ6 versus 118Ϯ4 mm Hg hearts at 50 ng of NE) (online-only Data Supplement Figure IIIA) . Similar results were obtained for contraction velocity dP/ dt max (online-only Data Supplement Figure IIIB ). These moderate effects may imply that, rather than the ROS scavenger Txn2, the corresponding reductase Txnrd2 might be of rate-limiting relevance during an I/R episode, prompting us to investigate cardiospecific Txnrd2-deficient hearts in this scenario.
Role of Thioredoxin Reductase-2 Deficiency During Ischemia/Reperfusion
We recently reported that ubiquitous inactivation and heartspecific disruption of Txnrd2 resulted in an embryonic and early postnatal lethal phenotype, respectively. 20 In order to study I/R injury in mice lacking mitochondrial Txnrd2, we generated a mouse strain that lost Txnrd2-expresssion in cardiomyocytes on tamoxifen induction (Figure 2A and online-only Data Supplement Methods). An organ-specific decrease of Txnrd2 protein levels was evident in the heart, but not in the liver, after tamoxifen induction (termed Txnrd2-/icϭinducible cardiospecific) ( Figure 2B ). This induced deletion of Txnrd2 was associated with an increase of its substrate, Txn2, without a detectable change in Txn1/Txnrd1 levels ( Figure 2B and online-only Data Supplement Figure  IVA) . Interestingly, we did not observe any impairment of LV function in Txnrd2-/-ic mice without I/R stress ( Figure  2C ) (LVDP 101Ϯ2 mm Hg at rest, 145Ϯ11 mm Hg with 50 ng of NE). In contrast, after I/R, we observed an aggravated loss of LVDP compared with Txnrd2ϩ/-ic at rest (71Ϯ2 versus 82Ϯ2 mm Hg) ( Figure 2C ) and after stimulation with NE (93Ϯ2 versus 113Ϯ4 mm Hg at 50 ng of NE). The latter finding was still present at 14 days (107Ϯ4 versus Figure IVB) . The deterioration of systolic function in Txnrd2-/-ic mice at 24 hours was mirrored in decay of contraction velocity dP/dt max , (6424Ϯ521 versus 8594Ϯ365 mm Hg/s at rest, 13803Ϯ1768 versus 18897Ϯ1532 mm Hg/s with 50 ng of NE) ( Figure 2D ). Of note, diastolic function, assessed by relaxation velocity dP/dt min , was not significantly altered by cardiospecific loss of Txnrd2 (Ϫ6574Ϯ457 versus Ϫ7519Ϯ1645 mm Hg/s in controls, 12012Ϯ1645 mm Hg/s in sham at rest) ( Figure 2E ). Moreover, no significant alteration in LVDP ( Figure 2F ) was obtained.
Augmented Mitochondrial Impairment, Increased Cell Death, and Larger Infarct Size on Ischemia/Reperfusion in Thioredoxin Reductase-2 Deficient Hearts
At a cellular level, transmission electron microscopy revealed losses of regularity of mitochondrial striation and of membrane integrity as early as 60 minutes after I/R in Txnrd2-/-ic mice ( Figure 3A) , which exceeded the levels seen in Txnrd2ϩ/-hearts. A mitochondrial score consisting of swelling, loss of striation, and membrane disintegrity (online-only Data Supplement Data Figure V) confirmed this observation: although no significant difference in mitochondrial integrity was obtained in normoxic hearts, mitochondrial disintegration was obvious after I/R ( Figure 3B ). As assessed by the release of H 2 O 2 , heart mitochondria produced more ROS on the addition of the respiratory chain complex I-and complex II-linked substrates in the absence of rotenone (succinate and succinateϩglutamateϩmalate group, respectively) ( Figure  3C ). Such reverse electron flow conditions (RET) produce ROS at complex I, 34 and similar values were obtained for isolated heart mitochondria compared with recently reported values for skeletal muscle mitochondria. 33 Importantly, under these conditions, Txnrd2-/-ic heart mitochondria produced a significantly higher emergence of ROS compared with Txnrd2ϩ/-heart mitochondria ( Figure 3C ). Rotenone, an inhibitor of complex I blocking the RET, led to a lower amount of H 2 O 2 for both Txnrd2ϩ/-and Txnrd2-/-ic heart mitochondria, being still higher for the latter. No significant difference was observed in H 2 O 2 levels between the Txnrd2ϩ/-and Txnrd2-/-ic heart mitochondria with the addition of antimycin. Interestingly, comparably low amounts of H 2 O 2 were observed for Txnrd2ϩ/-and Txnrd2-/-ic heart mitochondria with the addition of ADP. These data indicate that, with metabolic disturbances such as I/R, Txnrd2-/-ic heart mitochondria may produce more ROS. This prediction was further investigated by assessing activity of the redox-sensitive mitochondrial enzyme aconitase. In fact, we detected a significant decrease of aconitase activity in mitochondria derived from whole Txnrd2-/-ic hearts subjected to I (60 minutes) and R (30 minutes) compared with myocardial Txnrd2ϩ/-mitochondria after I/R ( Figure 3D) . No difference in aconitase activity was seen under normoxic conditions (online-only Data Supplement Figure VE) . In addition, the activity of aconitase was not significantly different between Txnrd1ϩ/-and Txnrd1-/-ic hearts after I/R ( Figure 3D) .
The impaired function and integrity in Txnrd2-/-ic heart mitochondria on I/R was associated with an increase in TUNEL-positive heart cells at 24 hours of reperfusion but not at rest ( Figure 3E and 3F) . Infarct size, a second hallmark of I/R injury, was enlarged in Txnrd2-/-ic mice compared with Txnrd2ϩ/-controls in the acute phase 24 hours after the insult (Figure 3G and 3H) and 14 days after the insult, a time point when scar formation is complete (online-only Data Supplement Figure 4C and 4D).
Thioredoxin Reductase-2 Deficiency Sensitizes Toward Mitochondrial Pore Opening and Subsequent Cell Death
A well-documented mechanism of I/R injury is opening of mitochondrial mPTPs, 35, 36 which can be inhibited by the interaction of cyclosporin A (CsA) with the prolylisomerase cyclophilin D located in the mitochondrial matrix. Notably, CsA application abolished the loss of systolic function after I/R in the Txnrd2-/-ic but not in the Txnrd2ϩ/-hearts ( Figure  4A and 4B) . Moreover, CsA was also able to decrease the number of TUNEL-positive cells in Txnrd2-/-ic hearts ( Figure 4C ) at the level of Txnrd2ϩ/-hearts. As delineated in Figure 4D , swelling of isolated mitochondria, a hallmark of mPTP-induced detriment, was also inhibited by CsA.
N-Acetylcysteine Rescues Postischemic Thioredoxin Reductase-2-Deficient Hearts
In order to test the hypothesis that the antioxidant NAC might compensate for the impaired regeneration of oxidized mitochondrial thiols, we first employed cell culture assays. Because murine embryonic fibroblast cell cultures from Txnrd2-/-mice did not display a detectable difference in cell death on hypoxia and reoxygenation (data not shown), we developed 3 alternative cell culture models of Txnrd2 deficiency: (1) vascular progenitor cells derived from ubiquitous Txnrd2-/-mice (eEPCs) ( Figure 5A Depending on the added substrates, a higher emergence of ROS was detected for mitochondria from Txnrd2-/-ic hearts, compared with mitochondria from Txnrd2ϩ/-hearts (nϭ3) *PϽ0.05 versus Txnrd2ϩ/-. No difference was observed when Txnrd1-/-ic (nϭ4) mitochondria were compared with Txnrd1ϩ/-hearts (nϭ8, nϭmeasurements). D, After I/R (60/30 minutes), mitochondrial ROS impaired aconitase activity to a larger extent in Txnrd2-/-ic (nϭ12) than in Txnrd2ϩ/-(nϭ10) mitochondria. No difference was observed when Txnrd1-/-ic (nϭ4) mitochondria were compared with Txnrd1ϩ/-hearts (nϭ4). Delta activityϭI/R level -level of normoxic mitochondria, set to 100%. *PϽ0.05). E and F, TUNEL staining (green TUNEL) in the ischemic myocardium revealed an increased frequency of apoptotic cells per number of total nuclei (blue nuclei, DAPI) after I/R in the absence of Txnrd2 (nϭ8 low power fields of 4 hearts per group). *PϽ0.05 versus Txnrd2ϩ/-. §PϽ0.05 versus sham Txnrd2ϩ/-. G and H, At 24 hours, infarct size (white area) was larger than area at risk (AAR; red area) in Txnrd2-/-ic hearts than in control hearts (nϭ4 hearts per group).*PϽ0.05 versus Txnrd2ϩ/-hearts. myocyte cell line (HL-1) in which Txnrd2 expression was experimentally decreased (Figure 5G and 5H) . 37 We analyzed the reduced glutathione pool after hypoxia/reoxygenation of eEPCs because glutathione (GSH) has been reported to be a valid surrogate parameter for thiol supply in various model organisms. 38, 39 As depicted in Figure 5B , NAC increased the GSH content in Txnrd2-/-eEPCs to levels found in untreated wild-type cells. Pretreatment with NAC caused a dramatic increase in cell survival of Txnrd2-deficient eEPCs after hypoxia and reoxygenation ( Figure 5C ) similar to pretreatment with the antioxidants GSH or ␣-tocopherol.
Analysis of ES cell-derived, contracting Txnrd2flox/ flox MerCreMer cardiomyocytes (online-only Data Supplement Video I) was performed after 72 hours' induction with tamoxifen when deletion of Txnrd2 expression was obtained ( Figure 5D ). Txnrd2-/-ES cell-derived cardiomyocytes staining positive for the cardiomyocyte-specific markers ␣MHC and actinin ( Figure 5E ) displayed an increased vulnerability toward hypoxia-reoxygenation stress, which was reversed to Txnrd2ϩ/-levels by NAC application (Figure 5F , online-only Data Supplement Video II). A similar effect was obtained in HL-1 cardiomyocytes, 37 displaying a reduced Txnrd2 expression after lentiviral transfection of Txnrd2-shRNA ( Figure  5G ). Again, decreased Txnrd2 expression sensitized toward hypoxia-reoxygenation induced cell death unless NAC was supplied ( Figure 5H ).
To verify that NAC is capable of normalizing the phenotype of Txnrd2-/-ic in vivo, we applied NAC intraperitoneally 30 minutes before the onset of ischemia. In these animals, pretreatment with NAC improved LVDP and contraction velocity significantly 24 hours after ischemia. In fact, performance reached the functional levels of Txnrd2ϩ/-mice treated with NAC ( Figure 6A and 6B) . NAC application even abolished the excess cell death ( Figure 6C ) and the mitochondrial detriment ( Figure 6D and 6E) observed in postischemic Txnrd2-deficient hearts. Moreover, NAC was capable of reducing butyl-hydroperoxide-induced mitochondrial ROS burden to a large extent ( Figure 6F ).
Discussion
Recently, mutations in the mitochondrial Txnrd gene have been identified to cause dilated cardiomyopathy. 40 In the present study, we provide evidence for an essential role of endogenous mitochondrial Txnrd2 in controlling I/R injury of the heart. To this end, we used mice in which exons 15-18 of the remaining Txnrd2 allele were flanked by Lox-P sites. On induction with tamoxifen, a cardiospecific Crerecombinase translocated to nuclei and excised the remaining Txnrd2 allele. 23 This strategy resulted in an approximately 70% loss of Txnrd2 expression in cardiac cells in vivo.
Such hearts subjected to LAD occlusion (90 minutes) and subsequent reperfusion displayed an early increase of mitochondrial swelling ( Figure 3A and 3B) , followed by enhanced cardiomyocyte cell death ( Figure 3E and 3F) and an aggravated I/R-induced functional detriment ( Figure 2C through  2F ). An increased infarct size was found in Txnrd2-deficient hearts after 24 hours ( Figure 3G and 3H) and up to 14 days of reperfusion (online-only Data Supplement Figure 4C ). Moreover, the sensitivity of Txnrd2-deficient cells for hypoxia/reoxygenation-induced detriment was blunted by exog- enous application of the antioxidants glutathione, ␣-tocopherol, and NAC, the latter replenishing the reduced glutathione pool ( Figure 5B and 5C ). After peritoneal application, NAC was capable of abolishing not only the postischemic increase in the rate of myocardial cell death, but also the loss of cardiac function of Txnrd2-deficient mice ( Figure 6A through  6D) . Because the cysteine provider NAC is known to attenuate cellular vulnerability caused by a lack of thiol-based antioxidant systems, be it either glutathione 41 or thioredoxin reductase-2, 20 this NAC effect indicates that Txnrd2 deficiency significantly accentuates oxidative stress. Apparently, this phenomenon is not overcome by Txn2 upregulation in Txnrd2-deficient mice ( Figure 2B ), most likely due to the inability of mitochondria to regenerate oxidized Txn2 in the absence of Txnrd2.
Programmed cardiomyocyte death has evolved as a hallmark of cellular detriment during reperfusion, 42 featuring direct caspase activation by cytochrome C released from Bax/Bak-permeabilized mitochondria. 43 Moreover, postischemic reperfusion is sufficient to induce opening of the mitochondrial permeability transition pore (mPTP). ROS are known to contribute to the opening of the mPTP, 44 triggering mitochondrial membrane potential (⌬⌿m) breakdown, accumulation of fluids in the matrix, swelling and rupture of the mitochondrial outer membrane, and subsequent cell death. 45 CsA, which inhibits cyclophilin D activity and subsequent mPTP opening, 36, 46 improved I/R injury in patients. 47 In our models, CsA was able to reverse the increased sensitivity of Txnrd2-deficient hearts and cells toward mPTP opening to background levels ( Figure 4A through 4D) .
Because thiol supplementation via NAC or inhibition of mPTP opening by CsA prevents excessive I/R injury, it is reasonable to conclude that lack of Txnrd2 expression specifically impairs detoxification of ROS generated within mitochondria. In this context, it is noteworthy that cardiomyocyte-specific Txnrd1 deficiency did not affect the postischemic outcome (Figure 1 ). However, in a different model of ischemia (30 minutes), application of recombinant human Txn1 helped to reduce infarct size and apoptotic index. 48 It appears likely that with increasing depth of I/R injury, mitochondrial Txnrd becomes more prominent as Txn regenerating enzyme. Supporting this notion, NAC as an exogenous thiol-providing ROS scavenger did not alter the func-tional state of postischemic Txnrd2ϩ/-control mice in our model. Consistently, in a recent clinical study, 49 NAC (2 x 1200 mg/d) did not increase the myocardial salvage of patients with ST elevation myocardial infarction, bona fide Txnrd2 carriers. Only in the instance of Txnrd2 deficiency did thiol supplementation by NAC attenuate I/R injury, enabling a functional improvement to the level of Txnrd2ϩ/control mice ( Figure 6A and 6B) .
In summary, we were able to demonstrate for the first time that cardiospecific deletion of Txnrd2 in the adult mouse heart induces an excessive vulnerability to I/R-induced injury. The underlying cellular mechanisms were increased mitochondrial ROS generation, impaired glutathione levels, increased sensitivity to mPTP opening, mitochondrial swelling, and, consequently, increased cell death and enhanced functional detriment. Rescue from Txnrd2 deficiencyinduced cardiomyocyte injury, which was provided by N-acetylcysteine as well as CsA, points to the ability of Txnrd2 to block ROS-mediated mPTP opening in the advent of I and R of the heart. Taken together, our results highlight the role of the mitochondrial thioredoxin system in cardiomyocyte I/R injury. also thank Dr Alexander Seiler for his help in isolating the embryonic stem cells from conditional thioredoxin reductase-2 knockout embryos. We thank Dr G. W. Bornkamm for fruitful discussions.
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